Johns Hopkins Researcher Advance Treatment of Tuberculosis By Targeting New Enzyme

Researchers at Johns Hopkins report they have laid the foundation to develop novel antibiotics that work against incurable, antibiotic-resistant bacteria like tuberculosis by targeting an enzyme essential to the production and integrity of bacterial cell walls.


Current News Releases

Submit comment

Allowed HTML tags: <a href="http://google.com">google</a> <strong>bold</strong> <em>emphasized</em> <code>code</code> <blockquote>
quote
</blockquote>